Related Experiment Video
Updated: Jan 15, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Neostigmine-Atropine Combination Triggered Stress Cardiomyopathy in a Healthy Patient: A Case Report and Literature
Aoumar G Chamma1, Wendy E Saliba1, Linda Chamma2
1Cardiology, University of Balamand, Beirut, LBN.
Stress-induced cardiomyopathy or Takotsubo syndrome represents a short-term heart condition that develops after experiencing sudden physical or emotional distress. The condition primarily affects postmenopausal women under stress, but drug-induced cases remain both uncommon and poorly identified. A 40-year-old female patient without heart conditions developed stress-induced cardiomyopathy after receiving standard-dose neostigmine-atropine during her elective laparoscopic cholecystectomy. The patient developed ventricular fibrillation, which needed immediate resuscitation just 50 seconds after drug administration. The patient developed Takotsubo cardiomyopathy symptoms with apical ballooning and severe mid-apical hypokinesis according to imaging results, even though coronary angiography showed normal results. The case demonstrates that neostigmine-atropine can cause serious cardiac issues in people with low-risk profiles and suggests using sugammadex as a safer alternative when available.
Stress-induced cardiomyopathy or Takotsubo syndrome represents a short-term heart condition that develops after experiencing sudden physical or emotional distress. The condition primarily affects postmenopausal women under stress, but drug-induced cases remain both uncommon and poorly identified. A 40-year-old female patient without heart conditions developed stress-induced cardiomyopathy after receiving standard-dose neostigmine-atropine during her elective laparoscopic cholecystectomy. The patient developed ventricular fibrillation, which needed immediate resuscitation just 50 seconds after drug administration. The patient developed Takotsubo cardiomyopathy symptoms with apical ballooning and severe mid-apical hypokinesis according to imaging results, even though coronary angiography showed normal results. The case demonstrates that neostigmine-atropine can cause serious cardiac issues in people with low-risk profiles and suggests using sugammadex as a safer alternative when available.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis III: Medical Management
Myocarditis I: Introduction

